manually intraoperatively; the electrocardiogram, blood pressure, oxygen saturation and end-tidal carbon dioxide were monitored continuously and maintained within normal limits. The procedure lasted 50 minutes and at completion the child was given neostigmine 80 micrograms and atropine 40 micrograms. Despite normothermia and normocapnia there were no spontaneous respiratory efforts. A Digistim peripheral nerve stimulator was applied to the facial nerve and later the common peroneal nerve. No response to train-of-four or tetanic stimulation could be detected. A provisional diagnosis of suxamethonium apnoea was made. After another hour of mechanical ventilation repeated examination of neuromuscular function showed no train-offour induced twitch. Blood samples were obtained for glucose, electrolytes and arterial blood gases. Blood glucose was 11.8 mmolll and the electrolytes were normal. The infant's temperature in the recovery ward was 36.4 qc. A transforaminal cranial ultrasound was performed to exclude a further cerebral vascular event.
It was decided to ventilate the child in the neonatal intensive care unit until return of neuromuscular function. The child was ventilated with FiOl of 0.21 at a rate of 35 and pressure 15/3 cmHlo. He maintained a saturation of 100<"10 and an ETCOz of 35-50 mmHg. The child remained apnoeic and unresponsive when reassessed at eight hours post procedure. Only one twitch could be elicited in response to train-of-four stimulation with marked fade in response to tetanic stimulation. At this stage it was decided not to give fresh frozen plasma or whole blood as their use is contentious given the safety of intermittent positive pressure ventilation and the risk of transfusion and infection. Spontaneous movements returned 18 hours post suxamethonium administration. He spontaneously extubated himself at 20 hours with no adverse effects. A blood sample taken three days after surgery revealed a plasma cholinesterase level of 2.2 U/l (reference range 8.0-20.0) and a dibucaine number of /lt1ae.\{I/C\'/U and In(ensive Cure, 1994 27, consistent with the homozygous state for atypical cholinesterase. Subsequent testing of the parents and the three-year-old male sibling showed they are all heterozygotes (Etu, Eta) ( Figure I ).
This child has had a subsequent anaesthetic with atracurium, air and halothane without prolongation of neuromuscular blockade or apnoea.
DISCUSSION
The incidence of abnormal pseudocholinesterase in neonates is unknown. Despite the lack of documentation in the literature the incidence is presumed to be the same as the adult population at 1:2,800 for the homozygous state and 1 :25 for the heterozygous state. 1 The trend to avoid the use of suxamethonium as a routine muscle relaxant in neonates has diminished the incidence of the occurrence of prolonged apnoea due to abnormal pseudocholinesterase. The normal range for plasma cholinesterase in adults is 8-20 U/l. A neonatal range has not been determined but is presumed to be the same. Reports conflict with regard to the influence of age and sex on the level of cholinesterase (ChE) activity in children and adults. At birth the activity is low and there is complete disagreement about ChE activity during the first six months of life. Early reports showed a dramatic increase in activity during the first three weeks of life to a level greater than that of adults which persists until the third year. Later reports indicated activity remains at 50<170 of adult levels until six months. Between three and six years the mean ChE level is 30070 above adult levels and then declines to adult levels at puberty.6 DmUCAINE Recent transfusion of banked blood has been reported to mask expression of genotypic pseudocholinesterase deficiency. ' .1 This child was not transfused pre-or intraoperatively.
Evaluation of neuromuscular recovery may also be difficult in the neonatal period; however, Cook et al. demonstrated no greater incidence of phase 2 blockade in neonates given 1.5 mg/kg suxamethonium and no significant prolongation of recovery time when compared with older children."
Duration of action of suxamethonium in neonates homozygous for abnormal enzyme is not well documented. Viby-Morgenson 5 demonstrated a linear relationship between the inverse plasma ChE activity and duration of apnoea and the time to 100070 of twitch height but this was in genotypically normal adults. The Danish cholinesterase research unit reported an average apnoea time of 92 minutes from 105 homozygous patients (range 25-140 min). The longest time of 170 minutes was in a patient homozygous for the silent gene (range 70-330 min). A case report by Home et al. 9 reports a seven-weekold infant with prolonged apnoea secondary to one silent gene and one abnormal gene. This infant required ventilation for 5.5 hours. A report by Gill et al. 7 reports apnoea lasting eight hours before being terminated with transfusion of fresh frozen plasma. Benzer 8 reported a three-week-old term infant with apnoea lasting two hours before termination with human cholinesterase.
In our case the treatment options included continued mechanical ventilation or transfusion of fresh frozen plasma or whole blood. Human cholinesterase is DIBUCAINE available only in Germany, Switzerland, and Austria. It is derived from donor plasma that is HBsAg negative and is heat treated to inactivate DNA viruses (CMV, Herpes) and RNA viruses (HIVl, HIV2, Polio).' Mechanical ventilation has traditionally been used as a treatment mode as it will have the same outcome as blood transfusion without the risks of transfusion reactions and infection. A recent report on use of blood products recommends avoiding transfusion in neonates unless the period of apnoea exceeds eight hours.
Given the long period of apnoea in this case and the continuing and expanding requirements for ventilated neonatal intensive care beds, ventilation may be a luxury we can no longer afford, especially if the duration is 20 hours. An effective treatment would free the bed more quickly.
Goldenhar's syndrome is a rare syndrome with defects related to the first and second branchial arches. These include eye and ear deformities as well as a number of features which make anaesthesia difficult in these infants. Airway obstruction and difficulty with tracheal intubation may result from a combination of micrognathia, unilateral mandibular hypoplasia and vertebral anomalies, including vertebral fusion and odontoid elognation. new method of awake intubation in an infant with Goldenhar's syndrome scheduled for tracheostomy.
CASE REPORT
A 19-day-olcl 3.6 kg infant with Goldenhar's syndrome was admitted with increasing respiratory distress, rhinorrhoea and poor feeding. The features of Goldenhar's syndrome included severe right hemifacial microsomia, mandibular hypoplasia, absence of the right ear and ossicular chain and atresia of the left ear combined with multiple ear skin tags (Figure 1 ). Marked deviation of the nasal septum was also present.
There were no difficulties with feeding or respiratory obstruction after birth, but an upper respiratory tract infection had precipitated the infant's admission.
Tachypnoea and significant sternal recession were noted on admission. Arterial oxygen saturation was
